Diabetes diagnosis and risk stratification using mr‑proadm
A technology of diabetes and diabetes, which is applied in the field of diabetes, can solve the problem that the suitability of diabetes diagnosis is not disclosed, and achieve the effect of rapid diagnosis
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0033] The MR-proADM test was performed as described by Morgenthaler et al. (Morgenthaler NG, Struck J, Alonso C, Bergmann A. Measurement of midregional proadrenomedullin in plasma with immunoluminometric assay. Clin Chem. 2005 Oct;51(10):1823-9).
[0034] MR-proADM was tested in 100 healthy subjects with undisturbed glucose tolerance, 60 patients with disturbed glucose tolerance and 200 patients with overt type II diabetes (abbreviated as "DM II"). These 200 patients were divided into 100 diabetic patients who did not suffer from any secondary diseases, and 100 diabetic patients who had already suffered from secondary diseases such as diabetic nephropathy and diabetic retinopathy.
[0035] image 3 show. MR-proADM values increased significantly with increasing severity of DM II. Two groups of DM II patients differed especially from healthy controls and patients with impaired glucose tolerance. Surprisingly, the highest MR-proADM values were found in DM II patients who ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com